Although there are molecular subtypes of BC based on the genetic makeup of the cancer, in actuality, the molecular subtypes depend on the degree of human epidermal growth factor receptor 2 (HER2) expression, Ki-67, progesterone receptor (PR), and estrogen receptor (ER). This evidence concerns the gene ESR1 and breast cancer.